Overview
Financials
Filing timeliness
No financial statement for 2024 – the filing deadline has passed. 1 of 1 financial statements was filed late (for 2023, 9 days late).
- 2024not filed
- 202324/07/2024
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2023.
Results vs industry
Industry
Authorized Representatives
Manner of representation
The President of the Management Board represents the company independently. A member of the management board may represent the company jointly with another member of the management board. The following persons are authorised to make declarations of will concerning the company's proprietary and non-proprietary rights and obligations and to sign on behalf of the company: - up to PLN 10,000.00: the President of the Management Board independently; - above PLN 10,000.00: two members of the management board acting jointly.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Artur Grzegorz Franikowskiage 48 | 52 | $1,404.65 | 28.5714% |
Jakub Franikowskiage 34 | 52 | $1,404.65 | 28.5714% |
Kasper Nawrockiage 41 | 26 | $702.32 | 14.2857% |
Marcin Tyrasage 51 | 26 | $702.32 | 14.2857% |
Natalia Więkage 34 | 26 | $702.32 | 14.2857% |
Artur Grzegorz Franikowski and Jakub Franikowski hold a combined 57.1% – the ownership structure indicates family control.
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Was a VAT taxpayer from 2023-08-01 to 2026-08-18.
Reason for removal: Art. 96 ust. 9a pkt 2 (VAT returns not filed for 3 consecutive months or a quarter)
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Instytut Biotechnologii Surowic i Szczepionek Biomed - Skrót Firmy Ibss BiomedS.A. | $37,103,878.54 | biomed.pl | ||
| Fagronsp. z o.o. | $21,715,187.73 | fagron.pl | ||
| Krakowskie Zakłady Zielarskie Herbapol w KrakowieS.A. | $7,294,338.51 | herbapol.krakow.pl | ||
| F1 PharmaS.A. | $272,113.66 | f1pharma.pl | ||
| Ampliconsp. z o.o. | $48,330.99 | amplicon.pl | ||
| Xenira Pharmaceuticalssp. z o.o. | $26,670.82 | xenirapharma.com | ||
| Sanford Biotechsp. z o.o. | $2,586.64 | sanfordbiotech.com | ||
| Cefeasp. z o.o. | $294.66 | cefea.pl | ||
| Auxilius PharmaS.A. | $0.83 | auxiliuspharma.com | ||
| Zakład Farmaceutyczny Amarasp. j. | $0.00 | amara.pl |
Change history
| Date | Event | |
|---|---|---|
| 2024-09-12 | Share capital change (18,000.00 PLN → 18,200.00 PLN) | |
| 2023-02-22 | Entered in the register |
FAQ
Last updated: 2026-04-20